Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew B Singleton

Showing results (11-20 of 397) with videos related to

Pageof 40
Sort By:
Human Molecular Genetics|March 28, 2008
Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controlsJavier Simón-Sánchez, Andrew B Singleton
Movement Disorders : Official Journal of the Movement Disorder Society|June 21, 2017
Make dopamine neurons great again: An exciting new therapeutic option in parkinson's diseaseLuis Bonet-Ponce, Andrew B Singleton
Movement Disorders : Official Journal of the Movement Disorder Society|July 7, 2017
Parkinson disease and clathrin coat dynamics at synapses, why not?Sara Saez-Atienzar, Andrew B Singleton
Neuro-Degenerative Diseases|November 30, 2011
Using DNA methylation to understand biological consequences of genetic variabilityDena G Hernandez, Andrew B Singleton
Science (New York, N.Y.)|March 28, 2015
Genetics. For complex disease genetics, collaboration drives progressAndrew B Singleton, Bryan J Traynor
Movement Disorders : Official Journal of the Movement Disorder Society|December 22, 2017
Leucine rich repeat kinase knockout (LRRK KO) mouse model: Linking pathological hallmarks of inherited and sporadic Parkinson's diseaseDorien A Roosen, Andrew B Singleton
Neurology|February 11, 2012
Does trans size matter in Huntington disease?Owen A Ross, Andrew B Singleton
Neuron|October 20, 2010
Nature versus nurture: death of a dogma, and the road aheadBryan J Traynor, Andrew B Singleton
Neurology|May 9, 2007
Clinical heterogeneity of ATP13A2 linked disease (Kufor-Rakeb) justifies a PARK designationAndrew J Lees, Andrew B Singleton
The Lancet. Neurology|April 21, 2009
What's the FUS!Bryan J Traynor, Andrew B Singleton
Pageof 40

Showing results (11-20 of 397) with videos related to

Sort By:
Pageof 40
Human Molecular Genetics|March 28, 2008
Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controlsJavier Simón-Sánchez, Andrew B Singleton
Movement Disorders : Official Journal of the Movement Disorder Society|June 21, 2017
Make dopamine neurons great again: An exciting new therapeutic option in parkinson's diseaseLuis Bonet-Ponce, Andrew B Singleton
Movement Disorders : Official Journal of the Movement Disorder Society|July 7, 2017
Parkinson disease and clathrin coat dynamics at synapses, why not?Sara Saez-Atienzar, Andrew B Singleton
Neuro-Degenerative Diseases|November 30, 2011
Using DNA methylation to understand biological consequences of genetic variabilityDena G Hernandez, Andrew B Singleton
Science (New York, N.Y.)|March 28, 2015
Genetics. For complex disease genetics, collaboration drives progressAndrew B Singleton, Bryan J Traynor
Movement Disorders : Official Journal of the Movement Disorder Society|December 22, 2017
Leucine rich repeat kinase knockout (LRRK KO) mouse model: Linking pathological hallmarks of inherited and sporadic Parkinson's diseaseDorien A Roosen, Andrew B Singleton
Neurology|February 11, 2012
Does trans size matter in Huntington disease?Owen A Ross, Andrew B Singleton
Neuron|October 20, 2010
Nature versus nurture: death of a dogma, and the road aheadBryan J Traynor, Andrew B Singleton
Neurology|May 9, 2007
Clinical heterogeneity of ATP13A2 linked disease (Kufor-Rakeb) justifies a PARK designationAndrew J Lees, Andrew B Singleton
The Lancet. Neurology|April 21, 2009
What's the FUS!Bryan J Traynor, Andrew B Singleton
Pageof 40